{
    "id": "24890496",
    "公司名稱": "霖揚生技製藥股份有限公司",
    "資本總額(元)": "4,000,000,000",
    "實收資本額(元)": "1,326,810,000",
    "代表人姓名": "徐_平",
    "公司所在地": "新竹科學園區苗栗縣竹南鎮科研路50-8號4樓",
    "登記機關": "國家科學及技術委員會新竹科學園區管理局",
    "核准設立日期": {
        "year": 2015,
        "month": 4,
        "day": 23
    },
    "最後核准變更日期": {
        "year": 2025,
        "month": 2,
        "day": 13
    },
    "所營事業資料": [
        [
            "C801010",
            "基本化學工業"
        ],
        [
            "C801030",
            "精密化學材料製造業"
        ],
        [
            "C802041",
            "西藥製造業"
        ],
        [
            "C802060",
            "動物用藥製造業"
        ],
        [
            "C802990",
            "其他化學製品製造業"
        ],
        [
            "CF01011",
            "醫療器材製造業"
        ],
        [
            "F107990",
            "其他化學製品批發業(限區外經營)"
        ],
        [
            "F108021",
            "西藥批發業"
        ],
        [
            "F108031",
            "醫療器材批發業"
        ],
        [
            "F208021",
            "西藥零售業"
        ],
        [
            "F208031",
            "醫療器材零售業"
        ],
        [
            "F401010",
            "國際貿易業"
        ],
        [
            "IC01010",
            "藥品檢驗業"
        ],
        [
            "IG01010",
            "生物技術服務業"
        ],
        [
            "IG02010",
            "研究發展服務業"
        ],
        [
            "",
            "研究、開發、設計、製造及銷售下列產品："
        ],
        [
            "",
            "1.蛋白質新藥與生物相似藥"
        ],
        [
            "",
            "(New Protein Molecules and Biosimilars）"
        ],
        [
            "",
            "2.製程開發服務業"
        ],
        [
            "",
            "（Process Development Services）"
        ],
        [
            "",
            "3.關節腔玻尿酸植入物"
        ],
        [
            "",
            "（Intraarticular hyaluronic acid implants）"
        ],
        [
            "",
            "4.ADI-PEG20 新藥研發"
        ],
        [
            "",
            "(The Development of New Drugs ADI-PEG20)"
        ],
        [
            "",
            "5.藥品之委託開發暨生產服務"
        ],
        [
            "",
            "(CDMO Service for pharmaceuticals)"
        ]
    ],
    "董監事名單": [
        {
            "序號": "0001",
            "職稱": "董事長",
            "姓名": "徐_平",
            "所代表法人": [
                0,
                "英屬開曼群島商霖揚藥業股份有限公司"
            ],
            "出資額": "42,875,000"
        },
        {
            "序號": "0002",
            "職稱": "董事",
            "姓名": "陳_文",
            "所代表法人": [
                0,
                "英屬開曼群島商霖揚藥業股份有限公司"
            ],
            "出資額": "42,875,000"
        },
        {
            "序號": "0003",
            "職稱": "董事",
            "姓名": "陳_哲",
            "所代表法人": [
                0,
                "英屬開曼群島商霖揚藥業股份有限公司"
            ],
            "出資額": "42,875,000"
        },
        {
            "序號": "0004",
            "職稱": "監察人",
            "姓名": "徐_雄",
            "所代表法人": [
                0,
                "英屬開曼群島商北極星藥業集團股份有限公司"
            ],
            "出資額": "89,806,000"
        }
    ],
    "經理人名單": [],
    "股權狀況": "僑外資",
    "章程所訂外文公司名稱": "Genovior Biotech Corporation",
    "複數表決權特別股": "無",
    "對於特定事項具否決權特別股": "無",
    "每股金額(元)": "10",
    "已發行股份總數(股)": "132,681,000",
    "登記現況": "核准設立"
}